Premier, Inc. has awarded Surfacide, LLC participation in a multi-source group purchasing agreement that includes its Helios™ UV-C Triple Emitter Disinfection Technology. The three-year contract became effective Nov. 15, 2014 and the award represents a multi-million dollar growth opportunity for the two companies over the contract period.
"We are extremely pleased to have been selected to partner with Premier to benefit all of its alliance members," says Gunner Lyslo, founder and chief executive officer of Surfacide, LLC. “Participation in this contract, which provides outstanding value to Premier members, also represents an opportunity to offer significant clinical and economic impact benefits through the reduction of multi-drug resistant pathogens that virtually all healthcare providers must deal with daily.”
Under the agreement, the patented Surfacide Helios technology will be the only triple emitter UV-C disinfection system offered by Premier to its clients.
Surfacide’s proprietary triple emitter approach overcomes the challenges facing all single-emitter UV-C systems -- shadows, distance and disinfection cycle time. Recent data indicate Surfacide can introduce effective energy dosage in significantly less time when compared to all single emitter systems at a very competitive cost. Incorporating multiple emitters offers the maximum reduction or eradication of bacteria, virus and spore in the least amount of time by reducing shadows and distance in the targeted area throughout a room.
Surfacide’s Helios systems are in use worldwide by nearly 50 healthcare facilities. Its UV-C triple emitter disinfection technology is able to disinfect the hard surfaces in a room or OR, while minimizing missed areas due to shadows by providing multiple UV-C light towers that can be placed simultaneously in several areas of a room while working in tandem. In addition, the light emitters can be decoupled providing three times the equipment. The process results in helping eliminate shadows and eliminating the labor demands of moving single emitters in multiple locations throughout the room. The mobile three-tower system is easily transported by an interlocking cart, which can be loaded and unloaded by a single operator. The system is controlled remotely, such that during activation of the system, no operator is present, and sensors automatically cut power to all towers in the event that a person enters the room or other motion is sensed.
Source: Surfacide, LLC
Streamlined IFU Access Boosts Infection Control and Staff Efficiency
June 17th 2025A hospital-wide quality improvement project has transformed how staff access critical manufacturer instructions for use (IFUs), improving infection prevention compliance and saving time through a standardized, user-friendly digital system supported by unit-based training and interdepartmental collaboration.
Spring Into Safety: How Seasonal Deep Cleaning Strengthens Hospital Infection Control
June 13th 2025Rooted in ancient rituals of renewal, spring-cleaning has evolved from cultural tradition to a vital infection prevention strategy in modern hospitals—one that blends seasonal deep cleaning with advanced disinfection to reduce pathogens, improve air quality, and protect patients.
AHE Exchange Summit 2025 Brings EVS and Infection Prevention Experts Together in Columbus, Ohio
June 9th 2025The Association for the Health Care Environment (AHE) is set to host its largest event of the year—Exchange Summit 2025—from June 8 to 11 in Columbus, Ohio. With over 600 environmental services (EVS) professionals expected to attend, this year’s conference focuses heavily on infection prevention, interdepartmental collaboration, and education that empowers frontline health care support leaders to improve patient safety and operational efficiency.
Far UV-C Light Shows Promise for Decontaminating Medical Equipment in Clinical Settings
June 4th 2025Manual cleaning gaps on shared hospital equipment can undermine infection control efforts. New research shows far UV-C light can serve as a safe, automated backup to reduce contamination in real-world clinical settings.